-
62. SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR AND COVID-19 INFECTION IN HEMODIALYSIS PATIENTS
I.Griveas
417 Army Share Fund Hospital of Athens, Greece
Nephrology Dialysis and Transplantation , May 2021, Volume 36, Supplement 1
-
63. COVID-19 INFECTION IN HEMODIALYSIS PATIENTS:FINDINGS-EXPERIENCE-OUTCOME
I.Griveas
417 Army Share Fund Hospital of Athens, Greece
Nephrology Dialysis and Transplantation , May 2021, Volume 36, Supplement 1
-
64. HEMOPERFUSION IN HEMODIALYSIS PATIENTS WITH COVID-19 INFECTION: IMPACT ON CLINICAL COURSE
I.Griveas
417 Army Share Fund Hospital of Athens, Greece
Nephrology Dialysis and Transplantation , May 2021, Volume 36, Supplement 1
-
65. Soluble urokinase plasminogen activator receptor and its complicated role in hemodialysis (HD) patients with Covid-19 infection
Ioannis Griveas1 , Antonios Schoinas2 , Anthi Balitsari3 , Gerasimos Asimakopoulos4 , Evaggelos Pratilas5 1 Medical
Nephrology Department, Army Share Fund Hospital of Athens, Greece, 417 NIMTS
ASIAN JOURNAL OF MEDICAL SCIENCES, July 2021
-
66. IgM and IgG antibody response to SARS-CoV-2 Infection and Viral RNA Persistence in hospitalized chronic kidney disease patients under Hemodialysis (HD)
Ioannis Grivea
Nephrology Department, Army Share Fund Hospital of Athens, Greece, 417 NIMTS
ASIAN JOURNAL OF MEDICAL SCIENCES, July 2021
-
67. SmartPD™ Automated Peritoneal Dialysis System as a New Sophisticated Choice for Urgent Integration in Replacement Therapy for a Patient with ESRD
Ioannis Griveas.
Army Share Fund Hospital of Athens, 417 NIMTS, Athens,
Greece.
JASN-SUPPELEMENT OCT 2021 FOR ASN-Renal week , San Diego , 4-7 November 2021
-
Five Years Experience of Therapeutic Apheresis in Nephrology Department
Ιoannis Griveas1, Georgios Visvardis2, Efstathios Mitsopoulos2.
Nephrology Department, 401 General Army Hospital of Athens1, and Nephrology Department, Papageorgiou General Hospital,Thessaloniki2, Greece.
Δημοσιεύθηκε στο Balkan Military Review 2010;13:9-16.
